Literature DB >> 24954839

Deoxycholic acid induced changes in electrophysiological parameters and macromolecular permeability in murine small intestine with and without functional enteric nervous system plexuses.

R A Forsgård1, R Korpela, L K Stenman, P Osterlund, R Holma.   

Abstract

BACKGROUND: We have previously shown in mice that the fecal proportion and concentration of the hydrophobic bile acid deoxycholic acid (DCA) is elevated with high-fat feeding and that these changes are able to disrupt the intestinal barrier function. The aim of this study was to investigate whether these changes are mediated by the enteric nervous system (ENS).
METHODS: The function of the ENS in the small intestinal tissues of mice was compromised by two different methods: by removing the seromuscular layer and by incubating the intact tissues with tetrodotoxin (TTX), a neural conduction blocker, before DCA treatment. Tissues with or without functional plexuses were mounted into a Ussing chamber system and treated with 3 mM DCA for 20 min. After DCA treatment, the intestinal permeability to fluorescein was assessed. Short-circuit current (Isc ) and transepithelial resistance (TER) were recorded throughout the experiment. KEY
RESULTS: DCA increased intestinal fluorescein permeability only in tissues where the seromuscular layer was removed. In tissues with intact seromuscular layer, DCA induced a significant increase in TER, which was attenuated by blocking of the neural function by TTX. CONCLUSIONS & INFERENCES: The results of this study suggest that the DCA-induced increase observed in fluorescein permeability is not mediated through neural pathways, but more due to a direct effect on the epithelium. However, as TTX was able to attenuate the DCA-induced increase in TER, it can be speculated that DCA is also able to elicit responses through neural pathways.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Ussing chamber; bile acids; enteric nervous system; intestinal barrier function; permeability

Mesh:

Substances:

Year:  2014        PMID: 24954839     DOI: 10.1111/nmo.12383

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  10 in total

Review 1.  The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.

Authors:  Andrea Shin; Geoffrey A Preidis; Robert Shulman; Purna C Kashyap
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-25       Impact factor: 11.382

2.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

3.  Fecal microbiome and bile acid metabolome in adult short bowel syndrome.

Authors:  Harold J Boutte; Jacqueline Chen; Todd N Wylie; Kristine M Wylie; Yan Xie; Mackenzie Geisman; Anirudh Prabu; Vered Gazit; Phillip I Tarr; Marc S Levin; Brad W Warner; Nicholas O Davidson; Deborah C Rubin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-24       Impact factor: 4.052

4.  Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.

Authors:  Rudra Pangeni; Jeong Uk Choi; Vijay Kumar Panthi; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2018-06-06

5.  Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin.

Authors:  Rudra Pangeni; Vijay Kumar Panthi; In-Soo Yoon; Jin Woo Park
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

Review 6.  The Role of Leaky Gut in Functional Dyspepsia.

Authors:  Lucas Wauters; Matthias Ceulemans; Jolien Schol; Ricard Farré; Jan Tack; Tim Vanuytsel
Journal:  Front Neurosci       Date:  2022-03-29       Impact factor: 4.677

7.  Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.

Authors:  Rudra Pangeni; Sang Won Choi; Ok-Cheol Jeon; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2016-11-30

Review 8.  Gut Microbiota Dysbiosis in Functional Dyspepsia.

Authors:  Georgios Tziatzios; Paraskevas Gkolfakis; Ioannis S Papanikolaou; Ruchi Mathur; Mark Pimentel; Evangelos J Giamarellos-Bourboulis; Konstantinos Triantafyllou
Journal:  Microorganisms       Date:  2020-05-08

9.  Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.

Authors:  Rudra Pangeni; Saurav Kumar Jha; Ruby Maharjan; Jeong Uk Choi; Kwan-Young Chang; Young Kweon Choi; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2019-08-08

10.  Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.

Authors:  Rudra Pangeni; Laxman Subedi; Saurav Kumar Jha; Seho Kweon; Seo-Hee Kang; Kwan-Young Chang; Jeong Uk Choi; Youngro Byun; Jin Woo Park
Journal:  Int J Nanomedicine       Date:  2020-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.